Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Pulmonary Hypertension

Free Subscription 09.11.2026 1 Am J Med 1 Am J Physiol Cell Physiol 1 Am J Respir Crit Care Med 1 Ann Am Thorac Soc 1 Arch Bronconeumol 1 Australas J Dermatol 1 Biol Pharm Bull 2 Cardiol Young 1 Circ Heart Fail 1 Circulation 1 Clin Cardiol 1 Clin Transl Med 2 Clin Transl Sci 1 Dis Model Mech 1 Drug Deliv 1 ERJ Open Res 1 Eur Heart J 2 Eur J Intern Med 1 Eur Respir J 1 Exp Ther Med 1 Free Radic Biol Med 1 Heart Lung 2 J Clin Invest 1 J Scleroderma Relat Disord 1 J Ultrasound Med 1 J Vis Exp 1 JACC Adv 1 Nat Commun 1 Nihon Yakurigaku Zasshi 1 Pediatr Res 2 Pulm Circ 3 Rev Cardiovasc Med 1 Scand J Rheumatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Med

1. NATIONS JA, Mordini FE, Khosla R, Lam PH, et al
   Echocardiographic estimates of pulmonary artery acceleration time and mortality risk in older adults.
   Am J Med. 2026 Oct 18:S0002-9343(26)00537-1. doi: 10.1016/j.amjmed.2026.
   PubMed         Abstract available
   
   

   
   Am J Physiol Cell Physiol

2. OLEJNICKOVA V, Kvasilova A, Naidu P, Perera N, et al
   Right heart remodeling in Sugen/hypoxia rat model of severe pulmonary hypertension.
   Am J Physiol Cell Physiol. 2026 Nov 6. doi: 10.1152/ajpcell.90222.2026.
   PubMed         Abstract available
   
   

   
   Am J Respir Crit Care Med

3. BRYANT AJ, Mickael C, Oldham WM
   Catch a TIGAR by the Tail: YTHDC1 Links Epitranscriptomic Regulation to Macrophage-Driven Pulmonary Hypertension.
   Am J Respir Crit Care Med. 2026 Oct 26:aamag537. doi: 10.1093.
   PubMed        
   
   

   
   Ann Am Thorac Soc

4. GILLMEYER KR, Rinne ST, Sun L, Wiener RS, et al
   Pulmonary hypertension clinic infrastructure is associated with improved care coordination: results from a national survey.
   Ann Am Thorac Soc. 2026 Nov 2:aaoag336. doi: 10.1093.
   PubMed        
   
   

   
   Arch Bronconeumol

5. BILLOTTE M, Camara H, Meyer A, Moulinet T, et al
   Longitudinal Trajectories of Antisynthetase Syndrome-associated Interstitial Lung Disease.
   Arch Bronconeumol. 2026;62:780-788.
   PubMed         Abstract available
   
   

   
   Australas J Dermatol

6. LAI VWY, Hansen D, Tabesh M, Fairley J, et al
   Telangiectasia in Systemic Sclerosis Is a Marker of Increased Disease Morbidity and Mortality: Analyses From the Australian Scleroderma Cohort Study.
   Australas J Dermatol. 2026;67:e431-e435.
   PubMed         Abstract available
   
   

   
   Biol Pharm Bull

7. HIKAWA Y, Nakahama K, Yamamura A, Kondo R, et al
   Intratracheal Administration of Benzbromarone Attenuates Pulmonary Vascular Remodeling and Improves Survival in Rats with Monocrotaline-Induced Pulmonary Hypertension.
   Biol Pharm Bull. 2026;49:1840-1845.
   PubMed         Abstract available
   
   

   
   Cardiol Young

8. DAS B, Maiya S, Khan B, Raj V, et al
   Transcatheter atrial flow regulator implantation in children with pulmonary arterial hypertension in resource-limited settings: a single-centre experience.
   Cardiol Young. 2026;36:1709-1712.
   PubMed         Abstract available
   
   
9. ACAR ALKAN BB, Dogan E, Tuncer ON, Vuran G, et al
   A rare late presentation of restrictive cor triatriatum sinister in a 14-year-old male mimicking refractory asthma.
   Cardiol Young. 2026;36:1716-1718.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

10. THAL BR, Kremer NC, Janetzko P, Douschan P, et al
    Exercise Right Atrial Stiffness From Pressure-Volume Loops and Prognosis in Pulmonary Hypertension.
    Circ Heart Fail. 2026 Nov 2:e014761. doi: 10.1161/CIRCHEARTFAILURE.126.014761.
    PubMed         Abstract available
    
    

    
    Circulation

11. HUANG X, Zhang J, Zeng Q, Lin M, et al
    Targeting ALDOA Lactylation Reverses Vascular Remodeling in Pulmonary Hypertension by Disrupting Actin Polymerization and YAP Activation.
    Circulation. 2026 Nov 3. doi: 10.1161/CIRCULATIONAHA.125.078300.
    PubMed         Abstract available
    
    

    
    Clin Cardiol

12. WANG Y, Li X, Huang Z, Duan A, et al
    Prognostic Implications of High HFpEF Probability in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Clin Cardiol. 2026;49:e70503.
    PubMed         Abstract available
    
    

    
    Clin Transl Med

13. CHEN D, Jin Q, Zhang L, Pan W, et al
    FSP1 as the convergent hub of autophagy and ubiquitination governing ferroptosis in monocrotaline-induced pulmonary arterial hypertension.
    Clin Transl Med. 2026;16:e70822.
    PubMed         Abstract available
    
    

    
    Clin Transl Sci

14. 
    Correction to "Impact of Stress Hyperglycemia Ratio on Adverse Outcomes in Patients With Chronic Thromboembolic Pulmonary Hypertension".
    Clin Transl Sci. 2026;19:e70754.
    PubMed        
    
    
15. SAMEED M, Waleed M, Colomy V
    Treprostinil: Mechanism of Action, Clinical, and Translational Science.
    Clin Transl Sci. 2026;19:e70749.
    PubMed         Abstract available
    
    

    
    Dis Model Mech

16. AYKAC I, Baumgartner CA, Hamza O, Kiss A, et al
    Comprehensive cardiac, vascular and pulmonary characterization of a cardiometabolic model of heart failure with preserved ejection fraction.
    Dis Model Mech. 2026;19:dmm053163.
    PubMed         Abstract available
    
    

    
    Drug Deliv

17. STENE HALLERBACK A, Edstrom M, Agvald P, Nilsson KF, et al
    Exploration of various administration routes for the nitric oxide donating organic nitrite, nitrosooxypropanol, in a porcine model.
    Drug Deliv. 2026;33:2752663.
    PubMed         Abstract available
    
    

    
    ERJ Open Res

18. SPYCHALSKA K, Jermakow M, Kucharska J, Dzikowska-Diduch O, et al
    D-dimer/NT-proBNP ratio in acute pulmonary embolism patients stratifies risk of chronic thromboembolic pulmonary hypertension.
    ERJ Open Res. 2026;12:00580-2026.
    PubMed         Abstract available
    
    

    
    Eur Heart J

19. LANG IM, Zelniker TA
    AMPK/USP10 loop activation of ACE2 in pulmonary hypertension: extending the cardiovascular-kidney-metabolic continuum to the pulmonary circulation?
    Eur Heart J. 2026 Nov 2:ehag762. doi: 10.1093.
    PubMed        
    
    

    
    Eur J Intern Med

20. BURJA B, Boubaya M, Bruni C, Christ L, et al
    Anti-Ro/SSA and rheumatoid factor antibodies are associated with more severe lung involvement in patients with systemic sclerosis: a study from the EUSTAR database.
    Eur J Intern Med. 2026;153:106898.
    PubMed         Abstract available
    
    
21. DARDI F, Donato F, Cennerazzo F, Niro F, et al
    Pulmonary artery dilation in pulmonary arterial hypertension: haemodynamic determinants and association with sudden death.
    Eur J Intern Med. 2026;153:106939.
    PubMed         Abstract available
    
    

    
    Eur Respir J

22. HALOUANI A, Mensah E, Ben Rhouma M, Athumani Z, et al
    Paracrine action of bone morphogenetic protein 3 in pulmonary arterial hypertension.
    Eur Respir J. 2026;68:2502146.
    PubMed         Abstract available
    
    

    
    Exp Ther Med

23. ZHANG H, Zhao Q, Sun J, Deng Y, et al
    Compensatory activation of PI3K/AKT signaling and apoptosis-associated protein expression in pulmonary hypertension-induced right ventricular dysfunction.
    Exp Ther Med. 2026;32:347.
    PubMed         Abstract available
    
    

    
    Free Radic Biol Med

24. GENG F, Deng LP, Guo Y, Chen PW, et al
    HnRnpk Mediated CircNtrk3 Downregulation Promotes Pulmonary Vascular Remodeling in Pulmonary Hypertension by Driving Ca(2+) Signaling and Metabolic Reprogramming.
    Free Radic Biol Med. 2026 Nov 5:S0891-5849(26)01258.
    PubMed         Abstract available
    
    

    
    Heart Lung

25. CROQUETTE M, Bertoletti L, Jutant EM, Trihan JE, et al
    Femoral venous stasis index improves risk classification in patients with pulmonary hypertension: a post-hoc analysis of the CODOVEIN study.
    Heart Lung. 2026;81:102994.
    PubMed         Abstract available
    
    

    
    J Clin Invest

26. SCHWARTZ MW, Bornfeldt KE
    Pulmonary arterial hypertension-associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases.
    J Clin Invest. 2026;136:e212006.
    PubMed         Abstract available
    
    
27. OKAWA S, Shi Y, Banerjee S, Tai YY, et al
    Cerebellar and frontal lobe alterations in pulmonary hypertension implicate an inflammatory lung vascular/brain axis.
    J Clin Invest. 2026;136:e195110.
    PubMed         Abstract available
    
    

    
    J Scleroderma Relat Disord

28. FARINA N, Bellando-Randone S, Sanges S, Jenssen Bjorkekjaer H, et al
    Association between bosentan and reduced detection of precapillary pulmonary hypertension in systemic sclerosis: evidence from a EUSTAR study.
    J Scleroderma Relat Disord. 2026;11:e000044.
    PubMed         Abstract available
    
    

    
    J Ultrasound Med

29. FATIMA E, Ullah S, Baig MF, Bai J, et al
    Letter to Editor on: Clinical Value of Real-Time 3-Dimensional Echocardiography for Evaluating Right Ventricular Structure and Function in Patients with Pulmonary Hypertension Across Different Echocardiographic Pulmonary Artery Systolic Pressure Strat
    J Ultrasound Med. 2026 Oct 31. doi: 10.1002/jum.70542.
    PubMed        
    
    

    
    J Vis Exp

30. SUN Z, Liu F
    Multimodal Artificial Intelligence Model Integrating Chest CT and Cardiac Ultrasound for the Auxiliary Diagnosis of Pulmonary Arterial Hypertension.
    J Vis Exp. 2026;.
    PubMed         Abstract available
    
    

    
    JACC Adv

31. AIKAWA T, Takahara M, Kuno T, Kohsaka S, et al
    Procedural Volume and Outcomes After Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    JACC Adv. 2026 Oct 14:103382. doi: 10.1016/j.jacadv.2026.103382.
    PubMed         Abstract available
    
    

    
    Nat Commun

32. GIUGNI FR, Santos M, Yang Y, Lamberson V, et al
    Large-scale proteomics identifies circulating markers of pulmonary pressure and pulmonary hypertension risk.
    Nat Commun. 2026;17:11345.
    PubMed         Abstract available
    
    

    
    Nihon Yakurigaku Zasshi

33. KOMATSU T, Uehara Y, Nemoto T
    [New trends in the treatment of pulmonary hypertension].
    Nihon Yakurigaku Zasshi. 2026;161:465.
    PubMed        
    
    

    
    Pediatr Res

34. ARCHAMBAULT JL, Posey JN, Jordan M, Roberts DS, et al
    Hypoxia-induced platelet activation and pulmonary platelets are increased in a murine model of neonatal chronic lung disease and pulmonary hypertension.
    Pediatr Res. 2026 Nov 3. doi: 10.1038/s41390-026-05543.
    PubMed         Abstract available
    
    

    
    Pulm Circ

35. SUTCLIFFE RL, Cuthbertson I, Moore S, Southwood M, et al
    Interrogating the Glycolytic Axis in Pulmonary Hypertension Models: Potential Targets for Therapy.
    Pulm Circ. 2026;16:e70444.
    PubMed         Abstract available
    
    
36. WU R, Zhang Y, Fu S, Xiong Y, et al
    Adiponectin and Pulmonary Hypertension Risk: Mendelian Randomization and Receptor-Side Genetic Evidence.
    Pulm Circ. 2026;16:e70449.
    PubMed         Abstract available
    
    

    
    Rev Cardiovasc Med

37. ZHOU K, Gong Y, Zhang J, Chen D, et al
    Breakthroughs in the Pathological Mechanism and Comprehensive Management of Pulmonary Hypertension.
    Rev Cardiovasc Med. 2026;27:50716.
    PubMed         Abstract available
    
    
38. CHEN X, Liu X, Wang J, Gao Q, et al
    Association of Exercise-Induced Pulmonary Hypertension and Echocardiographic Parameters of Cardiac Function: A Systematic Review and Meta-Analysis.
    Rev Cardiovasc Med. 2026;27:51027.
    PubMed         Abstract available
    
    
39. LIU A, Xi L, Du J, Guo Y, et al
    Advances in Mechanisms and Management Strategies of Pulmonary Hypertension: A Review.
    Rev Cardiovasc Med. 2026;27:49075.
    PubMed         Abstract available
    
    

    
    Scand J Rheumatol

40. BALCI MA, Yagbasan Z, Gunduz I, Bayindir Akbas AN, et al
    Factors associated with shorter time to death and causes of mortality among deceased patients with systemic sclerosis: a multicentre retrospective study.
    Scand J Rheumatol. 2026;55:447-457.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum